Global Vagal Nerve Stimulation (VNS) Market 2022-2028

The global vagal nerve stimulation market is set to achieve an incremental growth of USD 420 million, acelerating at a CAGR of almost 9.8% during the forecast period 2022-2028.

Vagus nerve stimulation (VNS) involves the use of a device to stimulate the vagus nerve with electrical impulses. VNS may be an option to reduce the frequency of seizures in people who haven't achieved control with medications. Vagus nerve stimulation may also be helpful for people who haven't responded to intensive depression treatments, such as antidepressant medications, psychological counseling (psychotherapy) and electroconvulsive therapy (ECT). According to Publisher, the global vagal nerve stimulation market is set to achieve an incremental growth of USD 420 million, acelerating at a CAGR of almost 9.8% during the forecast period 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global vagal nerve stimulation market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the vagal nerve stimulation industry.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for vagal nerve stimulation can be segmented by product: external VNS devices, implantable VNS devices. Among these, the implantable VNS devices segment was accounted for the highest revenue generator in 2021. Vagal nerve stimulation market is further segmented by application: depression, epilepsy, others. The epilepsy segment is estimated to account for the largest share of the global vagal nerve stimulation market. Based on end user, the vagal nerve stimulation market is segmented into: ambulatory surgical centers (ASCs), hospitals, others. On the basis of region, the vagal nerve stimulation market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW). By product: - external VNS devices - implantable VNS devices By application: - depression - epilepsy - others

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

By end user: - ambulatory surgical centers (ASCs) - hospitals - others By region: - North America - Asia Pacific - Europe - Rest of the World (ROW) The diagnosis market is further segmented into computed tomography (CT), magnetic Resonance Imaging (MRI), others. The CT segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period. Furthermore, the treatment market has been categorized into medication, surgery. According to the research, the medication segment had the largest share in the global vagal nerve stimulation market.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

The market research report covers the analysis of key stake holders of the global vagal nerve stimulation market. Some of the leading players profiled in the report include Boston Scientific Corporation, electroCore, Inc., ImThera Medical, Inc. (LivaNova PLC), Innovative Health Solutions, Inc, Inspire Medical Systems Inc, NeuroMetrix, Inc., Parasym Ltd, ReShape Lifesciences Inc., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global vagal nerve stimulation market. - To classify and forecast the global vagal nerve stimulation market based on product, application, end user, region. - To identify drivers and challenges for the global vagal nerve stimulation market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global vagal nerve stimulation market. - To identify and analyze the profile of leading players operating in the global vagal nerve stimulation market. Why Choose This Report - Gain a reliable outlook of the global vagal nerve stimulation market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • · Impact of COVID-19 pandemic
  • PART 5. MARKET BREAKDOWN BY PRODUCT
  • · External VNS devices
  • · Implantable VNS devices
  • PART 6. MARKET BREAKDOWN BY APPLICATION
  • · Depression
  • · Epilepsy
  • · Others
  • PART 7. MARKET BREAKDOWN BY END USER
  • · Ambulatory surgical centers (ASCs)
  • · Hospitals
  • · Others
  • PART 8. MARKET BREAKDOWN BY REGION
  • · North America
  • · Asia Pacific
  • · Europe
  • · Rest of the World (ROW)
  • PART 9. KEY COMPANIES
  • · Boston Scientific Corporation
  • · electroCore, Inc.
  • · ImThera Medical, Inc. (LivaNova PLC)
  • · Innovative Health Solutions, Inc
  • · Inspire Medical Systems Inc
  • · NeuroMetrix, Inc.
  • · Parasym Ltd
  • · ReShape Lifesciences Inc.
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Global Vagal Nerve Stimulation (VNS) Market 2022-2028

Contact usWe are friendly and approachable, give us a call.